Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 837 across all filing types
Latest filing 2023-08-14 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding a 'Nil Statement of Deviation(s) or Variation(s)' under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically relates to the quarter ended June 30, 2023, and confirms no deviation in the use of proceeds from a Preferential Allotment of Warrants. The document includes a detailed annexure showing the statement of deviation or variation in utilization of funds raised, which is nil. This is a regulatory compliance filing related to the use of funds raised and does not contain financial statements or detailed financial results. It is an announcement/report on compliance with regulatory requirements rather than a full financial report or earnings release. The document length is 4676 characters, which is relatively short and focused on regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-14 English
Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, we are enclosing Statement of Deviation(s) or Variation (s)
Regulatory Filings Classification · 95% confidence The document is a statement addressed to stock exchanges regarding the 'Nil Statement of Deviation(s) or Variation(s)' under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It pertains to the quarter ended June 30, 2023, and confirms no deviation in the use of proceeds from a Preferential Allotment of Warrants. The content is a compliance disclosure about fund utilization and deviations, not a full financial report or earnings release. It is a regulatory compliance filing related to capital raising but does not provide financial results or detailed financial statements. The document is relatively short (4676 characters) and serves as a formal regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Capital/Financing Update (CAP) or Earnings Release (ER).
2023-08-14 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited standalone and consolidated financial results for the quarter ended June 30, 2023. It includes financial figures, notes on accounting standards, audit committee review, and board approval dates. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The content contains actual financial data and analysis for the quarter, not just a brief announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-08-09 English
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith the copies of newspaper publication of Unaudited Standalone and Consolidated Financial Results ....
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited standalone and consolidated financial results for the quarter ended June 30, 2023. It includes financial figures such as total income, profit/loss before and after tax, earnings per share, and notes on accounting standards and audit reviews. The document references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that the results were approved by the Board of Directors and reviewed by the statutory auditor. The content is substantive financial data for a quarterly period, not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-08-09 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, which typically covers material events or information that a listed company must disclose to stock exchanges. The content focuses on operational highlights and future outlook for the first quarter (Q1), including revenue growth, plant commissioning, capacity expansion, and market positioning. It does not contain detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). The document length is 3326 characters, which is relatively short and more consistent with a regulatory announcement rather than a full report. There is no indication that this is a transcript, audit report, or other specific filing type. Therefore, the document best fits the category of a Regulatory Filing (RNS) as a general announcement of operational performance and outlook under SEBI regulations.
2023-08-09 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, Sadhana Nitro Chem Limited ("SNCL") would like to intimate your office.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, which typically covers material events or updates that a listed company must disclose to stock exchanges. The content focuses on operational highlights and future outlook for the first quarter (Q1), mentioning revenue growth, plant commissioning, capacity expansion, and market positioning. It does not contain detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). The document length is 3326 characters, which is relatively short and more consistent with a regulatory announcement or update rather than a full financial report. There is no indication that this is a full quarterly report or earnings release; rather, it is an operational update and outlook. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.